Imlifidase Utilization in Glanzmann Thrombasthenia With Anti-GPIIb/IIIa and Anti-HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant.

IF 2.4 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2024-11-05 DOI:10.1002/pbc.31412

Mohammad AlNajjar, Ryan Rochat, Amanda B Grimes, Amir Navaei, Todd Eagar, Caridad Martinez, Khalid Yassine, Robert Krance, Saleh Bhar

引用次数: 0

查看原文本刊更多论文

伊立菲酶在伴有抗 GPIIb/IIIa 和抗 HLA 同种免疫以及造血干细胞移植后严重血小板折返的格兰茨曼血栓形成症中的应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.